Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Health Outcomes Res Med. 2010 Jul;1(1):e61–e66. doi: 10.1016/j.ehrm.2010.03.002

Table 1.

Subject Characteristics at Baseline

Characteristics Control Vermedx P
Sample Size 3,512 3,856
Male (%) 48.1% 49.8% 0.15
Age at randomization (years)
 Mean 62.4 63.5 0.0005
 Median 62.6 64.1
 Range 19.0 to 98.8 18.4 to 96.7
 Age > 65 years 43.8% 48.0% <0.0001
Vermont resident 62.0% 55.5% <0.0001
Glycemic control at goal (A1C < 7.0%) 58.2% 55.2% 0.008
Cholesterol at goal (LDL < 100 mg/dl) 44.1% 44.8% 0.59
Creatinine normal (<1.5 mg/dl) 89.5% 89.8% 0.67
Microalbuminuria present (≥30 mg/gm) 28.7% 33.2% 0.007
HHS Vulnerability Disclosure